NCT06455982

Brief Summary

The present study will evaluate the effects on glucose, ketones and other blood biomarkers, cognition, quality of life, physical activity and well-being of a reduced carbohydrate diet paired with a ketogenic product for 2 months in a population living in a senior residence. This study follows the KetoHome (fall 2022) and SAGE (fall 2023) projects which assessed the feasibility, acceptability and effectiveness of a reduced carbohydrate intervention alone.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

3 months

First QC Date

June 6, 2024

Last Update Submit

June 6, 2024

Conditions

Keywords

Nutritional interventionGlucose monitoringReduced carb dietEnergy metabolismKetones

Outcome Measures

Primary Outcomes (3)

  • Plasma glucose concentration

    To evaluate the possible improvement in mean glucose concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    2 months

  • Plasma ketones concentration

    To evaluate the possible improvement in mean ketones concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    2 months

  • Plasma insulin concentration

    To evaluate the possible improvement in mean insulin concentration following a reduction in carbohydrates combined with an MCT supplement in people living in a senoir residence for 2 months.

    2 months

Secondary Outcomes (2)

  • Plasma triglycerides concentration

    2 months

  • Plasma cholesterol concentration

    2 months

Study Arms (1)

Delta of before/after the intervention

EXPERIMENTAL

2 months of reduced carbohydrate menu combined with a ketogenic MCT supplement

Dietary Supplement: reduced carbohydrate menu combined with ketogenic supplement

Interventions

Participants will eat a reduced carb menu for 2 months and they will take 15g of MCT in the morning and the evening for a total of 30g per day.

Also known as: RCHO+MCT
Delta of before/after the intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older men or women in a senior residence;
  • Understand, read and write French;
  • Have sufficient visual and hearing acuity to pass cognitive tests;
  • Available during the intervention period

You may not qualify if:

  • Body mass index \< 20;
  • T1 diabetic;
  • T2 insulin-dependent diabetic;
  • MMSE \< 20;
  • Weight loss \>10% in the last 6 months involuntary or voluntary;
  • Known and uncontrolled hypoglycemia;
  • Moderate to severe digestive illnesses that can be aggravated by dietary changes;
  • Severe dysphagia;
  • Supplementation with MCT oil, ketone salts, ketone esters, adherence to the ketogenic diet, reduced carbohydrate diet, intermittent fasting or other diet or supplements that can significantly increase ketones in the last month;
  • Participation in other interventional research projects on nutrition or aimed at metabolic change simultaneously.
  • Medical condition that could prevent the participant from completing the study in the opinion of the doctor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de recherche sur le vieillissement

Sherbrooke, Quebec, J1H 4C4, Canada

Location

MeSH Terms

Conditions

Ketosis

Condition Hierarchy (Ancestors)

AcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Participants will be compared to themselve (i.e. pre-intervention and post-intervention) The intervention will be 2 months of reduced carbohydrate menu combined with a ketogenic supplement (MCT)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2024

First Posted

June 13, 2024

Study Start

September 5, 2024

Primary Completion

December 15, 2024

Study Completion

December 15, 2025

Last Updated

June 13, 2024

Record last verified: 2024-06

Locations